European Journal of Organic Chemistry
10.1002/ejoc.201700904
FULL PAPER
(
C), 82.00 (C), 65.49 (C), 31.50 (CH
3
), 27.72 (CH
-DMSO) δ 9.37 (s, 1H), 7.34 (d, J = 8.2 Hz,
H), 7.27 (d, J = 2.0 Hz, 1H), 7.17 (dd, J = 8.2, 2.0 Hz, 1H), 3.17 (sept., J
6.8 Hz, 1H), 2.07 (s, 3H), 1.47 (s, 6H), 1.14 (d, J = 6.8 Hz, 6H); 13
-DMSO) δ 169.20 (C), 143.07 (C), 135.54 (C), 129.06
CH), 128.90 (CH), 126.94 (CH), 120.24 (C), 95.87 (C), 80.92 (C), 64.08
C), 32.11 (CH ), 27.27 (CH ), 23.68 (CH), 23.43 (CH ); IR: 3233.2 (br.
3
), 23.99 (CH), 22.94
(CH), 123.5 (C), 112.0 (CH), 26.0 (CH), 22.4 (CH
3
); IR: 3314.9 (w),
1
3 6
(CH ); H NMR (400 MHz, d
3196.2 (w), 2871.3 (br. m), 1687.1 (s), 1609.4 (s), 1507.1 (m), 1278.6 (s);
+
1
=
HRMS: Calcd for [C10
10 2 2
H N O Na] = 221.1266, found 221.1266, Δ = 0.0
C
ppm.
NMR (101 MHz, d
(
(
m), 2971.9 (m), 1658.5 (s), 1577.9 (w), 1520.2 (s) cm ; HRMS: Calcd for
16 2
[C H22NO ] = 260.1651, found 260.1648, Δ = -1.2 ppm.
6
4-(5-(2,6-dimethoxyphenyl)-3-(ethoxycarbonyl)-1H-pyrazol-1-yl)-3-
isopropylbenzoic acid (25)
3
3
3
-
1
mp: 218-220 °C; 1H NMR (400 MHz, CDCl
3
): 7.97 (d, J = 1.8 Hz, 1H),
7.85 (dd, J = 1.8, 8.2 Hz, 1H), 7.41 (d, J = 8.2 Hz, 1H), 7.23 (t, J = 8.4 Hz,
H), 6.96 (s, 1H), 6.45 (d, J = 8.4 Hz, 2H), 4.44 (q, J = 7.1 Hz, 2H), 3.63
(s, 6H), 2.77 (sept., J = 6.7 Hz, 1H), 1.40 (t, J = 7.1 Hz, 3H) 1.00 (br. s,
+
1
N-(4-(2,2-dibromo-3-hydroxy-3-methylbutanoyl)phenyl)acetamide
17)
Pale brown solid; Mp. 146.2-148.1 °C; LC-MS: Rt 4.70, [MH] = 436.1; H
400 MHz, d -DMSO) 9.50 (s, 1H), 8.25 (d, J = 2 Hz, 1H), 8.03 (dd, J =
.7, 2 Hz, 1H), 7.58 (d, J = 8.7 Hz, 1H), 5.55 (br. s, 1H), 3.27 (sept., J =
1
3
(
6H); C NMR (100 MHz, CDCl
(C), 144.3 (C), 142.5 (C), 138.9 (C), 131.6 (CH), 129.9 (C), 128.8 (CH),
128.6 (CH), 127.1 (CH), 111.5 (CH), 106.8 (C), 103.6 (CH), 61.1 (CH ),
55.6 (CH ), 27.8 (CH), 24.1 (CH ), 14.6 (CH ); IR: 2400-3300 (w br),
1713.9 (s), 1607.6 (m), 1589.9 (m), 1477.1 (m), 1229.1 (s); HRMS: Calcd
3
): 171.2 (C), 162.8 (C), 158.4 (C), 146.4
+
1
(
8
6
6
3
2
3
3
13
6
.8 Hz, 1H), 2.10 (s, 3H), 1.59 (s, 6H), 1.17 (d, J = 6.8 Hz, 6H); C (d -
+
DMSO) 190.0 (C), 168.5 (C), 140.7 (C), 139.9 (C), 131.1 (C), 129.9 (CH),
29.3 (CH), 124.8 (CH), 80.3 (C), 77.3 (C), 27.6 (CH ), 27.2 (CH ), 24.0
CH), 23.5 (CH ); IR 3431.2 (w), 3368.3 (w), 2160.5 (br. w), 2016.6 (w),
670 (s), 1598.7 (m), 1578.4 (m), 1506.0 (s), 1473.8 (m), 1456.9 (m),
for [C24
27 2 6
H N O ]
= 439.1869, found 439.1865, Δ = 0.9 ppm. The
1
(
1
1
3
3
structure was unambiguously confirmed by x-ray crystallography – CCDC
reference 1564267.
3
-
1
374.0 (w), 1356.0 (m), 1259.9 (s), 1211.9 (s), 1184.9 (s) cm ; HRMS:
+
Calcd for [C16
H21Br
2
NO
3
] = 432.9888, found 432.9887, Δ = 0.1 ppm. The
structure was unambiguously confirmed by x-ray crystallography – CCDC
reference 1564265.
Acknowledgements
4
-ethynyl-2-isopropylaniline (18)
We are greatful for financial support from the Royal Society (to
MB and IRB; UF130576 and UFUF150536 to MOK). We would
also like to thank Dr John Davies and Dr Andrew D. Bond at the
Department of Chemistry, University of Cambridge for solving
the X-ray structures of compounds 7, 8, 11, 17, 25 and 8a, 12a
+
1
Brown oil; LC-MS: Rt = 1.90, [MH] = 160.4; H NMR (CDCl
3
) 7.30 (d, J =
.85 Hz, 1H), 7.18 (dd, J = 8.1, 1.85 Hz, 1H), 6.58 (d, J = 8.1 Hz, 1H),
.83 (br. s, 2H, NH ), 2.99 (s, 3H), 2.83 (sept., J = 6.8 Hz, 1H), 1.25 (d, J
6.8 Hz, 6H); C NMR (CDCl ) 144.7 (C), 132.6 (C), 131.1 (CH), 130.1
).
1
3
=
2
13
3
(CH), 115.7 (CH), 111.9 (C), 85.4 (C), 75.1 (CH), 28.0 (CH), 22.5 (CH
3
+
HRMS: Calcd for [C11
H14N] = 160.1126, found 160.1126, Δ = 0.0 ppm.
(
see SI for details).
2
-hydroxyisobutyric acid (19)[43]
1
) δ 1.25 (s, 3H); 13C NMR (101 MHz, d
).
H NMR (400 MHz, DMSO-d
DMSO) δ 178.32 (C), 71.18 (C), 27.75 (CH
6
6
-
Keywords: Flow Chemistry • Neurotensin • Ozonolysis •
Sonogashira • multi-step synthesis
3
2
-hydroxyisobutyric acid methyl ester (20)[44]
1
H NMR (400 MHz, DMSO-d
6
) δ 5.30 (br. s, 1H), 3.61 (s, 3H), 1.27 (s,
H); C NMR (101 MHz, DMSO-d ) δ 176.85 (C), 71.55 (C), 52.07 (CH ),
7.72 (CH ).
[
1]
a) R. Carraway, R. S. E. Leeman, J. Biol. Chem. 1973, 248, 6854–
13
6
2
6
3
6861; b) W. H. Rostène, M. J. Alexander, Front. Neuroendocrinol. 1997,
3
18, 115–173.
methyl 4-amino-3-isopropylbenzoate (21)
[2]
E. Popp, A. Schneider, P. Vogel, P. Teschendorf, B. W. Böttigera,
Neuropeptides 2007, 41, 349–354.
Light tan solid; Mp. 96.0-97.8 °C; LC-MS: Rt = 2.23, [MH]+ = 194.7; 1
H
NMR (400 MHz, CDCl
Hz, 1H), 6.66 (d, J = 8.3 Hz, 1H), 4.12 (br. s, 2H), 3.88 (s, 3H), 2.87
3
) δ 7.87 (d, J = 2.0 Hz, 1H), 7.74 (dd, J = 8.3, 2.0
[
[
[
[
3]
4]
5]
6]
P. R. Dobner, Peptides 2006, 240, 2405–2414.
D. Zhao, C. Pothoulakis,Peptides 2006, 27, 24234–2444.
P, Kitabgi, Neurochem. Int. 1989, 14, 111–119.
13
(
sept., J = 6.8 Hz, 1H), 1.30 (d, J = 6.8 Hz, 6H). C NMR (101 MHz,
CDCl ) δ 167.53 (C), 147.96 (C), 131.33 (C), 128.82 (CH), 127.59 (CH),
19.95 (C), 114.64 (CH), 51.58 (CH ), 27.61 (CH), 22.03 (CH ); IR:
468.6 (m), 3367.6 (m), 3247.0 (w), 2954.8 (m), 1671.2 (s), 1601.5 (s),
508.6 (m) cm ; HRMS: Calcd for [C11
94.1190, Δ = 4.6 ppm.
3
a) G. Bissette, C. B. Nemeroff, M. W. Decker, J. S. Kizer, Y. Agid, F.
Javoy-Agid, Ann. Neurology 1985, 17, 324–328. b) G. Chinaglia, A.
Probst, J. M. Palacios, Neuroscience. 1990, 39, 351–360. c) F. St-
Gelais C. Jomphe, L.-É. Trudeau, J. Psychiatry Neurosci. 2006, 31,
1
3
1
1
3
3
-
1
+
H16NO
2
]
= 194.1181, found
2
29–245; d) L. Ferraro, S. Beggiato, D. O. Borroto-Escuela, L. Ravani,
4
-carboxy-2-isopropylbenzenediazonium chloride (22)
W. T. O'Connor, M. C. Tomasini, A. C. Borelli, L. F. Agnati, T. Antonelli,
S. Tanganelli, K. Fuxe, Curr. Protein & Peptide Sci. 2014, 15, 681–690.
M. Ocejo-García, S. I. Ahmed, J. M. Coulson, P. Woll. J. Lung Cancer
1
H NMR (400 MHz, DMSO-d6) δ 8.92 (d, J = 8.5 Hz, 1H), 8.27 (d, J = 1.8
Hz, 1H), 8.25 (dd, J = 8.5, 1.8 Hz, 2H), 3.51 (sept., J = 6.7 Hz, 1H), 1.37
[
7]
(d, J = 6.7 Hz, 6H);
2001, 33, 1–9.
2
-(2-(4-carboxy-2-isopropylphenyl)hydrazinyl)-2-oxoacetic acid (23)
[8]
9]
F. Souazé, S. Dupouy, V. Viardot-Foucault, E. Bruyneel, S. Attoub, C.
Gespach, A. Gompel, P. Forgez, Cancer Res. 2006, 66, 6243–6249.
J. C. Reubi, B. Waser, H. Friess, M. Buchler, J. Laissue, Gut 1998, 42,
Yellow solid; Mp. 147.5 °C decomposition; LC-MS: Rt = 0.97, [MH]+
=
1
267.3; H NMR (600 MHz, DMSO-d
6
) δ 12.2 (br. s, 1H), 10.35 (br. s, 1H),
[
7.77 (s, 1H), 7.67 (d, J = 1.5 Hz, 1H), 7.58 (dt, J = 8.5, 1.5 Hz, 1H), 6.62
546–555.
(dd, J = 8.5, 1.5 Hz, 1H), 3.09 (sept., J = 7.1 Hz, 1H), 1.21 – 1.11 (d, J =
13
[10] R. R. Giorgi, T. Chile, A. R. Bello, R. Reyes, M. A. H. Z. Fortes, M. C.
Machado, V. A. Cescato, N. R..; Musolino, M. D. Bronstein, D.
Giannella-Neto, M. L. Corrêa-Giannella, J. Neuroendocrinol. 2008, 20,
7
1
.1 Hz, 6H). C NMR (101 MHz, d
62.58 (C), 149.51 (C), 131.35 (C), 128.79 (CH), 126.78 (CH), 120.68
); IR: 3254.2 (br. m), 2972 (m),
6
-DMSO) δ 168.02 (C), 162.61 (C),
(C), 110.71 (CH), 26.33 (CH), 22.81 (CH
3
-
1
+
1667.3 (s), 1606.2 (s), 1520.1 (m) cm ; HRMS: Calcd for [C12H N O ] =
15 2 5
1052–1057.
267.0981, found 267.0993, Δ = 4.5 ppm.
[
11] P. Schaeffer, M. C. Laplace, A. Bernat, V. Prabonnaud, D. Gully, L.
Lespy, J. M. Herbert, J. Cardiovasc. Pharmacol. 1998, 31, 545–550.
2
-(4-carboxy-2-isopropylphenyl)hydrazin-1-ium chloride (24)
+
[12] P. Kitabgi, F. De Nadai, C. Rovère, J. N. Bidard, Ann. N.Y. Acad. Sci.
1992, 668, 30–42.
Light tan solid; Mp. >260 °C decomp.; LC-MS: Rt = 3.50, [MH] =221.1;
1
H (500 MHz, d
6
-DMSO): 12.55 (br. s, 1H), 10.32 (br. s, 1H), 8.40 (s, 1H),
7
.78 (d, J = 1.9 Hz, 1H), 7.76 (dd, J = 8.4, 1.9 Hz, 1H), 6.97 (d, J = 8.4
[13] G. A. Cain, T. E. Christos, A. L. Johnson, R. S. Pottorf, P. N. Confalone,
S. W. Tam, W. K. Schmidt, Bioorg. Med. Chem. Lett. 1993, 3, 2055–
13
Hz, 1H), 3.15 (sept., J = 6.8 Hz, 1H), 1.19 (d, J = 6.8 Hz, 6H). C (125
MHz, d -DMSO): 167.2 (C), 145.7 (C), 134.1 (C), 128.0 (CH), 126.5
6
2060.
This article is protected by copyright. All rights reserved.